Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody-Reference-Cited by-同舟云学术

Effect of chelator conjugation level and injection dose on tumor and organ uptake of 111In-labeled MORAb-009, an anti-mesothelin antibody

Published:2011-11 Issue:8 Volume:38 Page:1119-1127
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Shin In Soo,Lee Sang-Myung,Kim Hyung Sub,Yao Zhengsheng,Regino Celeste,Sato Noriko,Cheng Kenneth T.,Hassan Raffit,Campo Melissa F.,Albone Earl F.,Choyke Peter L.,Pastan Ira,Paik Chang H.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference30 articles.

1. Diagnosis of and therapy for solid tumors with radiolabeled antibodies and immune fragments;Carrasquillo;Cancer Treat Rep,1984

2. Phase I study of intravenous Lu-labeled CC49 murine monoclonal antibody in patients with advanced adenocarcinoma;Mulligan;Clin Cancer Res,1995

3. Radioimmunotherapy of interleukin-2R alpha-expressing adult T-cell leukemia with yttrium-90-labeled anti-Tac;Waldmann;Blood,1995

4. Similarities and differences in 111In- and 90Y-labeled 1B4M-DTPA antiTac monoclonal antibody distribution;Carrasquillo;J Nucl Med,1999

5. Imaging and phase I study of 111In- and 90Y-labeled anti-Lewis Y monoclonal antibody B3;Pai-Scherf;Clin Cancer Res,2000

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiolabeled Antibodies for Cancer Imaging and Therapy;Cancers;2022-03-11

2. [²¹³Bi]Bi³⁺/[¹¹¹In]In³⁺-neunpa-cycMSH: Theranostic Radiopharmaceutical Targeting Melanoma─Structural, Radiochemical, and Biological Evaluation;Bioconjugate Chemistry;2022-03-03

3. Not so innocent: Impact of fluorophore chemistry on the in vivo properties of bioconjugates;Current Opinion in Chemical Biology;2021-08

4. A Conjugation Strategy to Modulate Antigen Binding and FcRn Interaction Leads to Improved Tumor Targeting and Radioimmunotherapy Efficacy with an Antibody Targeting Prostate-Specific Antigen;Cancers;2021-07-11

5. Early administration of amatuximab, a chimeric high-affinity anti-mesothelin monoclonal antibody, suppresses liver metastasis of mesothelin-expressing pancreatic cancer cells and enhances gemcitabine sensitivity in a xenograft mouse model;Investigational New Drugs;2021-04-27